Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles A Goldstraw

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Annals of the Royal College of Surgeons of England|September 28, 2006
Prostate cancer treatment. The case for radical prostatectomyMiles A Goldstraw
BJU International|April 5, 2013
Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programmeMiles A Goldstraw
BJU International|September 14, 2013
Does inflammation reduce the risk of prostate cancer?Miles A Goldstraw, Roger S Kirby
BJU International|May 12, 2006
Do statins protect against prostate cancer?Miles A Goldstraw, Peter Amoroso, Roger S Kirby
BJU International|August 24, 2006
What are the risks of second cancer formation after radiotherapy to the prostate?Miles A Goldstraw, Heather Payne, Roger S Kirby
BJU International|November 28, 2006
The role of botulinum toxin in benign prostatic hyperplasiaMiles A Goldstraw, Roger S Kirby, Prokar Dasgupta
BJU International|April 18, 2007
What is the role of inflammation in the pathogenesis of prostate cancer?Miles A Goldstraw, John M Fitzpatrick, Roger S Kirby
BJU International|November 28, 2006
Prostate-specific antigen kinetics and the diagnosis and management of prostate cancerMiles A Goldstraw, John M Fitzpatrick, Roger S Kirby
BJU International|November 8, 2008
Optimizing erectile function after radical prostatectomyMiles A Goldstraw, Tim Lane, Thomas McNicholas, et al.
BJU International|July 31, 2007
Is obesity a risk factor for prostate cancer?Miles A Goldstraw, Dler Besrani, Peter Amoroso, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of the Royal College of Surgeons of England|September 28, 2006
Prostate cancer treatment. The case for radical prostatectomyMiles A Goldstraw
BJU International|April 5, 2013
Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programmeMiles A Goldstraw
BJU International|September 14, 2013
Does inflammation reduce the risk of prostate cancer?Miles A Goldstraw, Roger S Kirby
BJU International|May 12, 2006
Do statins protect against prostate cancer?Miles A Goldstraw, Peter Amoroso, Roger S Kirby
BJU International|August 24, 2006
What are the risks of second cancer formation after radiotherapy to the prostate?Miles A Goldstraw, Heather Payne, Roger S Kirby
BJU International|November 28, 2006
The role of botulinum toxin in benign prostatic hyperplasiaMiles A Goldstraw, Roger S Kirby, Prokar Dasgupta
BJU International|April 18, 2007
What is the role of inflammation in the pathogenesis of prostate cancer?Miles A Goldstraw, John M Fitzpatrick, Roger S Kirby
BJU International|November 28, 2006
Prostate-specific antigen kinetics and the diagnosis and management of prostate cancerMiles A Goldstraw, John M Fitzpatrick, Roger S Kirby
BJU International|November 8, 2008
Optimizing erectile function after radical prostatectomyMiles A Goldstraw, Tim Lane, Thomas McNicholas, et al.
BJU International|July 31, 2007
Is obesity a risk factor for prostate cancer?Miles A Goldstraw, Dler Besrani, Peter Amoroso, et al.
Pageof 2